The future is calling: Cell therapy @Janssen Pharmaceutica

23 November 2023 - Ghent ICC

During this session we will address the unmet needs of patients living with cancer as we will explore Janssen’s novel therapeutic strategies that are advancing treatment goals and improving patients’ lives.

Janssen will produce innovative cell therapies in Belgium for the treatment of certain types of cancer in Europe. Together with Legend Biotech, we are building our first state-of-the-art facilities both in Ghent and Beerse to make the manufacturing of CAR-T cell therapy possible.

The decision to build the new European production facility in Belgium is a recognition of the unique local life sciences ecosystem, which is highly regarded within the global innovative life sciences environment. The development and production of transformative therapies such as CAR-T cell therapy require great innovative strength and strong collaboration. By choosing Belgium, we are building on the significant presence and expertise of Janssen in the field of science and production, as well as the strong local know-how, infrastructure and talent.

Find out more about this innovative journey, the hope it brings for so many patients and the unique opportunities that are created for talent with a passion for biotechnology.

Bie Van de Vloet | Strategy Execution Lead, CAR-T EMEA Advanced Therapies SC. | Janssen Pharmaceutica

Bie joined Janssen Belgium in 2002. After holding various Supply Chain operation positions Bie transitioned to the Campus Strategic Office. Next to developing diverse strategies supporting campus growth, she focused on business development. She was instrumental in landing the Janssen EMEA CAR-T program @Belgium, next to supporting external programs like Blue App & CESPE.

Currently, Bie’s main responsibilities are to build a strong ecosystem for Janssen as a Cell Therapy company, to develop an expansion strategy & partnerships to enable inflow and development of talent, crucial to make a successful launch of Cell Therapy Manufacturing possible.

Bie has an academic background in Bio engineering & obtained an executive MBA from Antwerp Management School.

FULL PROGRAMME HERE